autologIX for Hair Restoration
“IGF-1 is the only growth factor correlated with hair follicle proliferation — standard PRP cannot concentrate it.”
The scientific rationale
Five independent meta-analyses published between 2023 and 2025, encompassing over 1,800 patients across 43 RCTs, converge on a consistent finding: PRP increases hair density by approximately 25–28 hairs per square centimeter versus placebo. Response rates range from 65% to 87%, with patient satisfaction exceeding 90% in recent trials.
But the most consequential finding for autologIX comes from Beitia et al. (2023): when all growth factors in PRP were analyzed for their relationship to cellular proliferation, IGF-1 was the ONLY factor that correlated significantly — and it was the only factor whose concentration did NOT correlate with platelet count. IGF-1 resides in plasma, not platelets. Standard centrifugation PRP achieves zero enrichment.
This matters because balding scalp follicles secrete significantly less IGF-1 than non-balding counterparts (Panchaprateep and Sinclair, 2014). The mechanism is now understood: DHT activates the androgen receptor/miR-221/IGF-1 pathway, directly suppressing IGF-1 mRNA in dermal papilla cells. IGF-1 promotes anagen entry and maintenance, stimulates matrix cell proliferation, inhibits apoptosis, and upregulates Wnt/beta-catenin signaling — the master switch of hair follicle cycling.
autologIX enriches IGF-1 through ultrafiltration because IGF-1 circulates in 30–150 kDa complexes with binding proteins — well above the 15 kDa membrane cutoff. It simultaneously delivers concentrated PDGF for dermal papilla proliferation, VEGF for perifollicular angiogenesis, and characterized exosomes carrying miRNAs that modulate follicle biology. The combination creates a more comprehensive biological signal than platelet concentration alone.
Clinical studies investigating autologIX outcomes for hair restoration are in development.
Key published evidence
Anitua, Tierno, and Alkhraisat 2025 — Meta-analysis of 43 RCTs (1,877 participants). Activated PRP significantly increases hair density versus placebo. Dermatology and Therapy.
Singh and Singh 2023 — Split-head double-blind RCT. Patients receiving more than 1 million platelets per microliter achieved 42% density increase versus 16% at lower concentrations (P < 0.001). IJDVL.
Beitia et al. 2023 — IGF-1 is the only growth factor correlated with cell proliferation in PRP; not correlated with platelet count. International Journal of Molecular Sciences.
Yuan et al. 2024 — Meta-analysis of 21 RCTs (628 women). PRP significantly enhanced both hair density and thickness in female pattern hair loss. Skin Research and Technology.
Limitations
No clinical trial has compared ultrafiltration-enriched PRP to standard PRP for hair outcomes. The IGF-1 enrichment advantage is supported by compositional logic and in vitro data, not direct clinical comparison.
References
- Anitua E et al. Dermatol Ther. 2025. https://pubmed.ncbi.nlm.nih.gov/39325190/
- Singh K, Singh S. Indian J Dermatol Venereol Leprol. 2023;89(5):720-728. https://pubmed.ncbi.nlm.nih.gov/36883576/
- Beitia M et al. Int J Mol Sci. 2023;24(6):5367. https://pubmed.ncbi.nlm.nih.gov/36835105/
- Yuan F et al. Skin Res Technol. 2024;30(7):e13849. https://pubmed.ncbi.nlm.nih.gov/39030894/
